PROVIDE METHODOLOGICAL, ETHICAL AND REGULATORY SUPPORT TO THE RESEARCH

The application of methodological expertise can lead to changes in clinical practice, indirectly contributing to a decrease in the costs of medicines and therapies and, finally, promote the allocation of resources on interventions aimed at developing safe and efficient health organizations and structures.

Contribute to a health products quality system

The pharmaceutical system regulates access to medicines to ensure that when a new drug enters into the market, there is a great evidence on efficacy and safety, so that doctors and patients can make targeted choices. In the European Union the approval of new drugs is centralized in the hands of the EMA (European Medicines Agency)

COLLECT AND SHARE DATA TO CREATE AN INTEGRATED SYSTEM

Information technology is a tool for the progress of scientific research, especially in the biomedical field. Distributes and makes available new knowledge in a short time, making the research activity very competitive in economic terms.

WORK ON MEDICINES THAT CAN CHANGE LIFE

Pharmaceutical innovation changes life. Patients should not be left out of progress and care information. A description of European policies in the field of rare diseases and orphan medicines is available on the European Commission website

Promote the centrality of patient

When a person gets sick and and it turns out affected by a rare pathology, his life changes radically. They are diseases often united by difficulties in diagnosis and lack of information and awareness by institutions and the social-health staff

fondazione per la ricerca farmacologica
gianni benzi onlus

Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus is a not-for-profit Scientific Research Organization, with the aim of continuing the work carried on by professor Gianni Benzi, who dedicated his life to promoting the transformation of the most recent biological and pharmacological discoveries into human medicines. We promote research in biological, medical and pharmaceutical areas, with particular reference to patients affected by rare diseases and other populations with specific therapeutic needs, including elderly and children.

Our work is inspired by 3 crucial values we learned from professor Gianni Benzi and we truly share:

ethics

because we work to improve the patients quality of life

PASSION

which is the flame that drives us to carry on our activities, despite the difficulties

TRANSPARENCY

because we work to inform and raise awareness of all the interested people

HIGHLIGHTS

Delve into some of the most important activities now running at Fondazione Gianni Benzi

CHANGE IN REGULATORY SCIENCES IN THE EU
XI

CHANGE IN REGULATORY SCIENCES IN THE EU

How to move from a reactive to a multi-stakeholders proactive attitude

Change in Regulatory Sciences is a continuous challenging process! The challenge is to align scientific and patients’ objectives with regulatory requirements along the whole development process of health products. Moreover, all the stakeholders should be aware of the criteria by which the authorisation and access to products will be measured and decided to cover patients’ specific needs.

read more
c4c, better medicines for babies, children and young people

c4c, better medicines for babies, children and young people

c4c (conect4children) is a 6-years EU project setting up a large collaborative paediatric network that will facilitate the development of new drugs and other therapies for the entire paediatric population in Europe. 33 academic and 10 industry partners, more than 50...

read more

NEWS

Keep updated on all the initiatives and events of the Gianni Benzi Onlus Foundation dedicated to the comparison of research and training topics.

EPTRI presentation in Barcelona

The EPTRI project has been presented at the “Partnerships in clinical trials Europe” conference in Barcelona, a big event aimed at accelerating clinical development and improving trial quality by evaluating and enhancing clinical practices and alliances.

read more

World AIDS Day: what this means for EPIICAL project

December 1 marks the AIDS World Day, founded in 1988 to unite people worldwide in the fight against HIV, to show support for people living with HIV, and to commemorate those who have died from an AIDS-related illness. The EPIICAL project endorses this initiative, representing the largest international consortium of well-known scientists involved in the management and treatment of paediatric HIV infection.

read more

CloSed Final Project Meeting in Amsterdam

The CloSed consortium met in Amsterdam for the final project meeting on 6 to 7 November 2018. The Dutch patient association involved in the project, VSOP (Vereniging Samenwerkende Ouder – en Patiëntenorganisaties), hosted this meeting at the Crowne Plaza Amsterdam – South.

read more

PARTNERSHIPS

We collaborate with universities, institutions and research centers all over Europe with a unique goal: to foster and support the pharmacological, medical and biological research.

Pin It on Pinterest

Share This